• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

FDA Drug Shortages

  • Print
  • Share
  • E-mail
-

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

 Cefazolin Injection

 Status: Currently in Shortage

 » Date first reported: 04/01/2014
 » Therapeutic Categories: Anti-Infective; Pediatric

Apotex Corp. (Reverified 09/24/2014)

Company Contact Information:
800-706-5575

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
1gm; (25 Vials) (NDC 60505-0749-5) On backorder Manufacturing of the product has resumed and is back in distribution as of the last week in May 2014. The ongoing manufacturing will enable the resolution of the shortage. Demand increase for the drug
1gm; (25 Vials)(NDC 60505-6093-5) Currently available but limited supply Manufacturing of the product has resumed and is back in distribution as of the last week in May 2014. The ongoing manufacturing will enable the resolution of the shortage. Demand increase for the drug
10 gm; (10 Vials) (NDC 60505-0769-0) On backorder Manufacturing of the product has resumed and is back in distribution as of the last week in May 2014. The ongoing manufacturing will enable the resolution of the shortage. Demand increase for the drug
10 gm; (10 Vials) (NDC 60505-6094-0) Currently available but limited supply Manufacturing of the product has resumed and is back in distribution as of the last week in May 2014. The ongoing manufacturing will enable the resolution of the shortage. Demand increase for the drug

B. Braun Medical Inc. (Revised 06/19/2014)

Company Contact Information:
800-227-2862

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
2 g Cefazolin (NDC 0264-3105-11) Product available No shortage
1 g Cefazolin NDC (NDC 0264-3103-11) Shortage anticipated for 3 months Demand increase for the drug

Baxter Healthcare (Reverified 09/29/2014)

Company Contact Information:
888-229-0001

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
USP 1 g/50 mL (NDC 0338-3503-41) Available Demand increase for the drug

Fresenius Kabi USA, LLC (Reverified 09/11/2014)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
500 mg / single dose vial (NDC 63323-0236-10) Backordered. Next release anticipated October 2014. Demand increase for the drug
1 g / single dose vial (NDC 63323-0237-10) Backordered. Next release anticipated October 2014. Demand increase for the drug
10 g / PBP (NDC 63323-0238-61) Backordered. Next release anticipated October 2014. Check wholesalers for inventory. Demand increase for the drug
20 g / PBP (NDC 63323-0446-66) Backordered. Next release anticipated Q4 2014. Demand increase for the drug

Hospira, Inc. (Revised 09/18/2014)

Company Contact Information:
877-946-7747

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
1 g; vial (NDC 0409-0805-01) Available Please check with your wholesaler for available inventory. Shortage of Manufacturer: Available. Other
10 g; Pharmacy Bulk Package (NDC 0409-0806-01) Next delivery: TBD Please check with your wholesaler for available inventory. Shortage of Manufacturer: Manufacturing delay. Other
1 g; Add-Vantage vial (NDC 0409-2585-01) Next delivery September 2014; Estimated recovery TBD Please check with your wholesaler for available inventory. Demand increase for the drug

Sagent Pharmaceuticals (Reverified 09/29/2014)

Company Contact Information:
866-625-1618

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
500mg 10mL vial, (NDC 25021-100-10) This product is on allocation. Shortage per Manufacturer: Manufacturing delays Delay in shipping of the drug
1g 10mL vial, (NDC 25021-101-10) This product is on allocation. Shortage per Manufacturer: Manufacturing delays Delay in shipping of the drug

Sandoz (Reverified 09/29/2014)

Company Contact Information:
800-525-8747

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
500 mg (NDC 00781-9338-95) Ongoing backorder expected through October 2014 due to high sales. Resumed manufacturing Other
500 mg (NDC 00781-3450-95) Ongoing backorder expected through October 2014 due to high sales. Resumed manufacturing Other
1g (NDC 00781-3451-96) Ongoing backorder expected through October 2014 due to high sales. Waiting for release Other
10g (NDC 00781-3452-95) Ongoing backorder expected through October 2014 due to high sales. Waiting for release Other

West-Ward Pharmaceuticals (Revised 09/08/2014)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
1 g/10 mL vial (NDC 0143-9924-90) West-Ward currently has a tamporary backorder situation on the 1 g and 10 g vials. Limited quantities of the 500 mg are available. Additional lots are schedueld for manufacturing with anticipated avaialbility in the September - October 2014 timeframe. Product will be available as it is released. Increase in product demand due to market supply issues
10 mg/100 mL vial (NDC 0143-9983-03) West-Ward currently has a tamporary backorder situation on the 1 g and 10 g vials. Limited quantities of the 500 mg are available. Additional lots are schedueld for manufacturing with anticipated avaialbility in the September - October 2014 timeframe. Product will be available as it is released. Increase in product demand due to market supply issues
500 mg/10mL vial (NDC 0143-9923-90) West-Ward currently has a tamporary backorder situation on the 1 g and 10 g vials. Limited quantities of the 500 mg are available. Additional lots are schedueld for manufacturing with anticipated avaialbility in the September - October 2014 timeframe. Product will be available as it is released. Increase in product demand due to market supply issues

WG Critical Care (Revised 09/22/2014)

Company Contact Information:
888-493-0861

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
500mg vial (NDC 44567-0706-25) Product is on backorder. Product recently shipped to wholesalers. Please check wholesalers for availability. Demand increase for the drug
1g vial (NDC 44567-0707-25) Product is on backorder. Product recently shipped to wholesalers. Please check wholesalers for availability. Demand increase for the drug
10g vial (NDC 44567-0708-10) Product is currently available. Product continues to be manufactured and released to wholesalers. Demand increase for the drug
-
-